Loading
A live screen of the small-cap universe ordered by coverage-gap score — a composite of analyst count, last-coverage-change recency, and fundamental signal strength. Filter by cap, exchange, sector, and tier. Every row links to a source-backed profile.
State is in the URL. Share a filtered screen by copying the link.
| Ticker | Name · sector | Cap | ADV | Analysts | Tier | Gap , sorted descending | Why surfaced |
|---|---|---|---|---|---|---|---|
| GLACOTC | Glacier Insurance Holdings Financials | $76M | $0.2M/d | 0 | no coverage | 89 | OTC listing, sub-$80M cap, combined ratio improvement not modeled anywhere. |
| NLNHYOTC | Synd Energy Utilities | $65M | $0.3M/d | 0 | no coverage | 89 | Bookings disclosure expanded; consensus model still references the prior format. |
| MTXYVNASDAQ | Orval Foods Consumer | $98M | $0.3M/d | 0 | no coverage | 89 | Capacity-utilization step-up not present in the prior analyst note's model. |
| WLARNASDAQ | Wallarica Apparel Consumer | $142M | $0.5M/d | 0 | no coverage | 88 | Private-label revenue tripled in FY25, no sell-side, screen flagged inventory normalization. |
| SJRQFNYSE | Aldra Bancshares Financials | $140M | $0.7M/d | 0 | no coverage | 87 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| CTRAAMEX | Catara Resources Energy | $88M | $0.3M/d | 0 | no coverage | 86 | Sub-$100M cap, FCF positive on hedge book alone, full undrawn revolver. |
| VSPKAMEX | Falcrest Chemicals Materials | $195M | $0.4M/d | 0 | no coverage | 86 | Combined-ratio improvement on a tiny float; OTC listing keeps it off institutional desks. |
| ENGEAMEX | Ravell Health Healthcare | $124M | $0.5M/d | 0 | no coverage | 86 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| SHXZNAMEX | Zephir Energy Energy | $508M | $0.4M/d | 0 | no coverage | 86 | Combined-ratio improvement on a tiny float; OTC listing keeps it off institutional desks. |
| DXMCNASDAQ | Ulmar Apparel Consumer | $214M | $1.2M/d | 0 | no coverage | 86 | Capacity-utilization step-up not present in the prior analyst note's model. |
| CJNGNASDAQ | Idun Power Energy | $254M | $1.2M/d | 0 | no coverage | 85 | No-coverage screen flag; recent insider buying not yet modeled. |
| OAKMNYSE | Oakmoor Bancshares Financials | $198M | $0.6M/d | 0 | no coverage | 84 | CRE concentration plus rate-cycle inflection, no analyst voice since 2024. |
| ZGYJAMEX | Tarne Trust Financials | $33M | $0.1M/d | 0 | no coverage | 84 | Tenant credit migration in the latest 10-K not yet flagged by the small-cohort sell-side. |
| NDKEYAMEX | Conduit Financial Financials | $134M | $0.4M/d | 0 | no coverage | 83 | Regulatory change opens a reimbursement vector the last sell-side note didn't price. |
| CQDKAMEX | Ulmar Power Utilities | $184M | $0.3M/d | 0 | no coverage | 83 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| TJKMNASDAQ | Ulmar Bio Healthcare | $461M | $2.0M/d | 0 | no coverage | 83 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| GQGVNYSE | Penna Bancshares Financials | $505M | $2.8M/d | 0 | no coverage | 83 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| USCSPNYSE | Orval Gas Utilities | $449M | $0.7M/d | 0 | no coverage | 83 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| QEUJTNYSE | Conduit Water Utilities | $280M | $1.2M/d | 0 | no coverage | 82 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| SLCUBOTC | Lumar Insurance Financials | $66M | $0.4M/d | 0 | no coverage | 81 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| YCNNNASDAQ | Borvel Steel Materials | $91M | $0.5M/d | 0 | no coverage | 81 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| EBRWNYSE | Xander Steel Materials | $288M | $1.7M/d | 0 | no coverage | 81 | Channel structure obscures sell-through; alt-data flags acceleration. |
| AZDCOTC | Halcyon Energy Utilities | $425M | $0.9M/d | 0 | no coverage | 81 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| FLDSNASDAQ | Fields Specialty Consumer | $138M | $0.5M/d | 0 | no coverage | 80 | Channel structure obscures velocity; veterinary scrip data flags FY26 acceleration. |
| WSGFOTC | Junos Bio Healthcare | $282M | $1.2M/d | 0 | no coverage | 80 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| SGCPZNASDAQ | Ulmar Brands Consumer | $371M | $2.3M/d | 0 | no coverage | 80 | Capacity-utilization step-up not present in the prior analyst note's model. |
| JFRDNASDAQ | Ember Apparel Consumer | $287M | $1.3M/d | 0 | no coverage | 80 | Bookings disclosure expanded; consensus model still references the prior format. |
| NSKUNASDAQ | Zephir Materials Materials | $366M | $0.6M/d | 0 | no coverage | 80 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| ZEBRNYSE | Zebra Steel Wire Materials | $96M | $0.3M/d | 0 | no coverage | 79 | Sub-$100M cap, OEM concentration overstated by sell-side that no longer covers. |
| GWSQXAMEX | Vante Pet Consumer | $222M | $0.3M/d | 0 | no coverage | 79 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| QGWXAMEX | Garran Power Energy | $194M | $0.7M/d | 0 | no coverage | 79 | Capacity-utilization step-up not present in the prior analyst note's model. |
| DPUMCOTC | Penna Therapeutics Healthcare | $466M | $1.8M/d | 0 | no coverage | 79 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| QORMNASDAQ | Qorm Diagnostics Healthcare | $184M | $0.6M/d | 1 | low coverage | 78 | Single sell-side voice; reimbursement code expansion 2026-Q2 not yet modeled by consensus. |
| RUPMOTC | Ember Diagnostics Healthcare | $256M | $0.5M/d | 0 | no coverage | 78 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| KRYONASDAQ | Kryo Storage Healthcare | $168M | $0.7M/d | 1 | low coverage | 76 | Single coverage, governance review opened by audit committee not modeled by sell-side. |
| ZVJWVAMEX | Zephir Pet Consumer | $96M | $0.4M/d | 1 | low coverage | 76 | Regulatory change opens a reimbursement vector the last sell-side note didn't price. |
| UCZNNASDAQ | Borvel Therapeutics Healthcare | $351M | $0.9M/d | 0 | no coverage | 75 | Bookings disclosure expanded; consensus model still references the prior format. |
| GNRBAMEX | Ember Health Healthcare | $30M | $0.0M/d | 2 | low coverage | 75 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| WPGHNYSE | Hexor Sciences Healthcare | $49M | $0.2M/d | 1 | low coverage | 74 | No-coverage screen flag; recent insider buying not yet modeled. |
| NVCTNASDAQ | Novicort Bio Healthcare | $178M | $0.8M/d | 1 | low coverage | 73 | Single coverage and Phase 3 readout post-coverage refresh; consensus has stale model. |
| WCRULAMEX | Lumar Oil Energy | $96M | $0.3M/d | 1 | low coverage | 73 | Bookings disclosure expanded; consensus model still references the prior format. |
| EVTRNASDAQ | Evertron Power Utilities | $286M | $1.0M/d | 1 | low coverage | 72 | Capacity auction outcome materially exceeded model; single coverage hasn't refreshed. |
| AFVVOTC | Drayve Therapeutics Healthcare | $72M | $0.5M/d | 1 | low coverage | 72 | Capacity-utilization step-up not present in the prior analyst note's model. |
| FDGJUAMEX | Aldra Insurance Financials | $213M | $0.9M/d | 1 | low coverage | 72 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| MJQJNASDAQ | Westra Therapeutics Healthcare | $284M | $1.0M/d | 1 | low coverage | 72 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| RHXJHNYSE | Yarrow Outdoor Consumer | $213M | $0.2M/d | 1 | low coverage | 72 | Combined-ratio improvement on a tiny float; OTC listing keeps it off institutional desks. |
| BTHENYSE | Bethel Foods Consumer | $248M | $0.9M/d | 1 | low coverage | 71 | DTC subsegment growing 28% YoY but reported only in aggregate; one analyst, no segment model. |
| REPLNASDAQ | Replion Therapeutics Healthcare | $156M | $0.8M/d | 1 | low coverage | 70 | Catalyst-driven cohort, single coverage, no consensus model post-Phase-2 readout. |
| JGLRNASDAQ | Vante Energy Utilities | $199M | $0.8M/d | 2 | low coverage | 70 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| JJVMOTC | Penna Financial Financials | $210M | $0.8M/d | 2 | low coverage | 69 | Channel structure obscures sell-through; alt-data flags acceleration. |